Human Genome Epidemiology Literature Finder
Records 1 - 5 (of 5 Records) |
Query Trace: Hepatitis B and CFB[original query] |
---|
Genetic variants in five novel loci including CFB and CD40 predispose to chronic hepatitis B.
![]() Hepatology (Baltimore, Md.) 2015 Jul 62 (1): 118-28. Jiang De-Ke, Ma Xiao-Pin, Yu Hongjie, Cao Guangwen, Ding Dong-Lin, Chen Haitao, Huang Hui-Xing, Gao Yu-Zhen, Wu Xiao-Pan, Long Xi-Dai, Zhang Hongxing, Zhang Youjie, Gao Yong, Chen Tao-Yang, Ren Wei-Hua, Zhang Pengyin, Shi Zhuqing, Jiang Wei, Wan Bo, Saiyin Hexige, Yin Jianhua, Zhou Yuan-Feng, Zhai Yun, Lu Pei-Xin, Zhang Hongwei, Gu Xiaoli, Tan Aihua, Wang Jin-Bing, Zuo Xian-Bo, Sun Liang-Dan, Liu Jun O, Yi Qing, Mo Zengnan, Zhou Gangqiao, Liu Ying, Sun Jielin, Shugart Yin Yao, Zheng S Lilly, Zhang Xue-Jun, Xu Jianfeng, Yu Lo |
A non-synonymous variant rs12614 of complement factor B associated with risk of chronic hepatitis B in a Korean population. BMC medical genetics 2020 Dec 21 (1): 241. Seo Jung Yeon, Shin Joong-Gon, Youn Byeong Ju, Namgoong Suhg, Cheong Hyun Sub, Kim Lyoung Hyo, Kim Ji On, Shin Hyoung Doo, Kim Yoon J |
A missense variant in complement factor B (CFB) is a potential predictor of 24-week off-treatment response to PegIFNa therapy in Chinese HBeAg-positive chronic hepatitis B patients. Alimentary pharmacology & therapeutics 2020 Jan . Chen Haitao, Sun Jian, Zhou Bin, Peng Jinxin, Xie Qing, Liang Xieer, Fan Rong, Conran Carly, Xu Jianfeng, Ji Yuan, Zhang Xinxin, Sun Li, Jia Jidong, Wang Guiqiang, Hou Jinlin, Jiang De- |
A Missense Variant in Granulysin is Associated with the Efficacy of Pegylated-Interferon-Alpha Therapy in Chinese Patients with HBeAg-Positive Chronic Hepatitis B. Pharmacogenomics and personalized medicine 2021 12 14 1505-1515. Li Jing, Chen Haitao, Chen Jiaxuan, Zhou Bin, Hou Jinlin, Jiang De- |
TRIM26 inhibits hepatitis B virus replication by promoting HBx degradation and TRIM26 genetic polymorphism predicts PegIFN? treatment response of HBeAg-positive chronic hepatitis B Patients. Alimentary pharmacology & therapeutics 2022 Jul . Luo Mengqi, Hou Jia, Mai Haoming, Chen Jiaxuan, Chen Haitao, Zhou Bin, Hou Jinlin, Jiang De- |
- Page last reviewed:Feb 1, 2023
- Page last updated:Jun 02, 2023
- Content source: